Phase 3 Readout~month

Phase 3 Topline: A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-double

Indication
Fallopian Tube Cancer; Platinum-resistant Ovarian Cancer; Primary Peritoneal Cancer

Other upcoming events for GNLX

Phase 2 ReadoutPhase 2 Readout: olvi-vec

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-double — GNLX Phase 3 Readout | BioSniper